Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -991.90K | -803.00K | -922.30K | -1.53M | -718.60K |
| Total Depreciation and Amortization | 35.00K | 36.70K | 60.70K | 134.60K | 111.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 527.90K | 350.80K | 479.20K | 568.10K | 66.70K |
| Change in Net Operating Assets | 235.30K | 224.70K | -74.30K | -134.80K | 47.30K |
| Cash from Operations | -193.70K | -190.80K | -456.70K | -961.10K | -492.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 10.90K | 22.90K | 123.90K | 1.06M |
| Total Debt Repaid | -240.10K | -100.00K | -29.10K | -42.90K | -424.60K |
| Issuance of Common Stock | 475.00K | 309.00K | 580.50K | 1.30M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -94.90K | -- |
| Cash from Financing | 170.70K | 160.60K | 421.50K | 957.30K | 465.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -23.00K | -30.20K | -35.20K | -3.80K | -27.30K |
